A. Fanouriakis

Cardiology and Cardiovascular Medicine · 2019–2023

A researcher in the Science corpus: 4 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom A. Fanouriakis trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Massimo F. Piepoli
  2. George Bertsias

Papers from A. Fanouriakis's perspective

Ordered by how strongly the researchers A. Fanouriakis trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Definition and initial validation of a Lupus Low Disease Activity State (LLDAS) (Annals of the Rheumatic Diseases)
  2. Syndromes of thrombotic microangiopathy. (New England Journal of Medicine)
  3. 2016 European Guidelines on cardiovascular disease prevention in clinical practice (International Journal of Behavioral Medicine)
  4. Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular… (European Journal of Cardiovascular Prevention & Rehabilitation)
  5. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. (New England Journal of Medicine)
  6. Association of socioeconomic position with health behaviors and mortality. (Journal of the American Medical Association (JAMA))
  7. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. (Journal of the American Medical Association (JAMA))
  8. Triglycerides and the Risk of Coronary Heart Disease: 10 158 Incident Cases Among 262 525 Participants in 29 Western Prospective Studies (Circulation)
  9. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. (Archives of Internal Medicine)
  10. Lipoprotein(a) as a cardiovascular risk factor: current status (European Heart Journal)

Their papers